Orient EuroPharma Co., Ltd. logo

Orient EuroPharma Co., Ltd. (4120)

Market Closed
12 Aug, 05:30
TWSE TWSE
NT$
49. 00
-0.3
-0.6085%
NT$
- Market Cap
- P/E Ratio
90% Div Yield
44,127 Volume
- Eps
NT$ 49.3
Previous Close
Add Transaction
Day Range
48.35 49.6
Year Range
42.6 57.5
Want to track 4120 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Orient EuroPharma Co., Ltd. (4120) Statistics

Valuation metrics

Market Cap -
Enterprise value 5.85B
Trailing P/E (ttm) -9.68
Forward P/E -
PEG ratio 0.23
Price/Sales (ttm) 0.93
Price/Book (mrq) 0.75
Enterprise Value/Revenue 1.27
Enterprise Value/EBITDA 131.75

Overview

Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 100.51K
Average volume (90 days) 53.52K

Price summary

52-Week low 42.6
52-Week high 57.5
Beta -
50-Day moving average 46.62
200-Day moving average 45.97

Dividends and splits

Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate 4
Trailing annual dividend yield 0.0815%
5-Year annual dividend yield -
Payout ratio -0.22
Dividend Date 6 Aug 2026
Ex-Dividend Date 20 Jul 2026
Last split factor 1,160:1,000
Last split Date 28 Jul 2010

Financials

Fiscal year

Fiscal year ends -
Most recent quarter (mrq) -

Profitability

Profit margin -0.09%
Operating margin -0.04%

Operational effectiveness

Return on assets -0.03%
Return on equity -0.06%

Income Statement

Revenue (ttm) -
Revenue per share (ttm) 52.91
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -4.63
Quarterly earnings growth (yoy) -

Balance Sheet

Total cash (mrq) -
Total cash per share (mrq) 21.63
Total debt (mrq) -
Total Debt/Equity (mrq) 0.59
Current ratio (mrq) 1.38%
Book value per share (mrq) 77.88

Cash Flow

Cash flow statement -
Levered free cash flow (LFCF) -